Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
AdAPT: Brincidofovir vs Standard of Care for Adenovirus in Pediatric HCT
NCT03339401Phase 2Terminated
- Sponsor
- Chimerix Inc.
- Start
- Dec 2017
- Primary completion
- May 2019
- Modality
- Metabolically Activated Prodrugs
- Countries
- 9
01
Overview
A Phase 2 trial of brincidofovir in adenovirus infection, sponsored by Chimerix Inc.. Started Dec 2017; status: terminated.
02
Drugs
brincidofovir
03
Conditions
adenovirus infection
Beyond the preview
Go deeper on NCT03339401.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03339401.